Island Pharmaceuticals Limited (ILA.AX)
AUD 0.18
(2.94%)
AUD 0.18
(2.94%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.16 Million | -2.7 Million | -1.87 Million | -938.23 Thousand | -16.00 | -376 Thousand |
| Net Income | -2.86 Million | -2.83 Million | -2.6 Million | -2.12 Million | -658.00 | -430 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 297.61 Thousand | 448.43 Thousand | 1.15 Million | - | 43 Thousand |
| Change in working capital | -851.87 Thousand | -256.4 Thousand | 407.73 Thousand | 60.9 Thousand | -16.00 | 11 Thousand |
| Other non-cash items | 551.24 Thousand | 80.47 Thousand | -126.91 Thousand | -27.78 Thousand | 674.00 | - |
| Investing Cash Flow | - | - | - | 77.37 Thousand | - | - |
| Investments in PPE | -2.00 | - | - | - | - | - |
| Acquisitions | - | - | - | 77.37 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 77.37 Thousand | - | - |
| Financing Cash Flow | 2.78 Million | -171.35 Thousand | - | 7.29 Million | - | 1.59 Million |
| Debt repayment | -198.6 Thousand | -171.35 Thousand | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -132.14 Thousand | - | - | -221.92 Thousand | - | - |
| Common Stock Issuance | 2.72 Million | - | - | 7.5 Million | - | - |
| Other Financing Activities | -9763.00 | -180.35 Thousand | - | 19.95 Thousand | - | 1.59 Million |
| Accounts receivables | -873.43 Thousand | 3659.00 | 38.25 Thousand | -59.13 Thousand | -16.00 | - |
| Accounts payables | 465.31 Thousand | -330.05 Thousand | 312.72 Thousand | 229.8 Thousand | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 21.56 Thousand | 69.98 Thousand | 56.74 Thousand | -109.77 Thousand | - | 11 Thousand |
| Cash at beginning of period | 1.99 Million | 4.78 Million | 6.46 Million | 1.00 | 230 Thousand | 35 Thousand |
| Cash at end of period | 1.66 Million | 1.99 Million | 4.78 Million | 6.46 Million | 1.00 | 1.21 Million |
| Capital Expenditure | -2.00 | - | - | - | - | - |
| Effect of forex changes on cash | 40.49 Thousand | 90.94 Thousand | 204.43 Thousand | 23.47 Thousand | - | -38 Thousand |
| Net cash flow / Change in cash | -337.88 Thousand | -2.78 Million | -1.67 Million | 6.46 Million | -229.99 Thousand | 1.18 Million |
| Free Cash Flow | -3.16 Million | -2.7 Million | -1.87 Million | -938.23 Thousand | -16.00 | -376 Thousand |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.86 Million | -854.62 Thousand | -854.62 Thousand | -1.15 Million | -577.53 Thousand | -2.83 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | 297.61 Thousand |
| Change in working capital | -386.55 Thousand | -425.93 Thousand | -425.93 Thousand | - | - | -256.4 Thousand |
| Other non-cash items | 484.28 Thousand | 373.73 Thousand | 373.73 Thousand | -200.12 Thousand | -98.11 Thousand | 80.47 Thousand |
| Investing Cash Flow | - | - | - | 12.82 Thousand | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 2.79 Million | 1.24 Million | 1.24 Million | 307.34 Thousand | 151.71 Thousand | -171.35 Thousand |
| Debt repayment | -198.6 Thousand | -108.73 Thousand | - | -307.34 Thousand | - | -171.35 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.59 Million | 2.59 Million | - | - | - | - |
| Other Financing Activities | - | 1.24 Million | 1.24 Million | 151.71 Thousand | 151.71 Thousand | -180.35 Thousand |
| Accounts receivables | -873.43 Thousand | -436.71 Thousand | -436.71 Thousand | - | - | 3659.00 |
| Accounts payables | 465.31 Thousand | - | - | - | - | -330.05 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 21.56 Thousand | 10.78 Thousand | 10.78 Thousand | - | - | 69.98 Thousand |
| Cash at beginning of period | 1.99 Million | 976.04 Thousand | - | 1.99 Million | - | 4.78 Million |
| Cash at end of period | 1.66 Million | 1.66 Million | 342.16 Thousand | 976.04 Thousand | -511.1 Thousand | 1.99 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | 7427.00 | 7427.00 | 12.82 Thousand | 12.82 Thousand | 90.94 Thousand |
| Net cash flow / Change in cash | -337.88 Thousand | 684.32 Thousand | 342.16 Thousand | -1.02 Million | -511.1 Thousand | -2.78 Million |
| Free Cash Flow | -3.17 Million | -906.82 Thousand | -906.82 Thousand | -1.35 Million | -675.64 Thousand | -2.7 Million |
688798
BHARTIHEXA
0579
LTA
NEOINFRA
UD